The BBC reports on new research describing the structure of telomerase, an enzyme long known to be implicated in tumor cells. The study, from scientists at the Wistar Institute in Philadelphia, "could lead to drugs which switch it off," the article says. The structural information could be key to providing molecular targets for therapeutics.